The back-and-forth in the patent dispute between Samsung and Apple continues, with Samsung filing a request for a U.S. import ban against the iPhone, iPad and iPod, FOSS Patents reports . The complaint was filed with the International Trade Commission (ITC) on Tuesday. The ITC is a government regulatory body, which acts independently of the courts. Apple seems to be gearing up for a preliminaryinjunctionrequest in its legal case against Samsung in the U.S. District Court for the Northern District of California, but it hasnt sought any action from the ITC, unlike in previous cases against competing smartphone manufacturers such as HTC . Samsungs move is a clever way to beat Apple to a potentially hobbling import ban, since the ITCs decision is independent of the ongoing court case, and a final decision is reached within a fairly set time frame of 16 to 18 months, once the ITC agrees to investigate. Apple is likely to respond with a complaint of its own, according to FOSS Patents Floria...
Tesla's China business is booming Hong-Kong traded Tencent, a company best known for its WeChat messaging app, disclosed in a Tuesday filing that it's taken a 5 percent stake in Tesla for $1.78 billion. The investment follows Tencent's new stake in taxi-hailing app Didi Chuxing, which can be accessed through WeChat. "I think Tencent likely wanted exposure to a company that was growing very quickly in electric and autonomous" vehicles, said Tasha Keeney, an analyst on the ARK Industrial Innovation ETF (ARKQ) , whose top holding is Tesla. "We think the autonomous mobility as a service market could be $10 trillion in gross sales globally by the early 2030s, and companies like Tesla or Baidu could take a cut of that," she said. Tesla declined to comment to CNBC. Tencent did not respond to emailed requests for comment. A Tencent spokesperson told The Wall Street Journal that "Tesla is a global pioneer at the forefront of new te...
Add to My Stories Share Artificial blood created from stem cells could be tested on Britons within two years. The scientists behind the research, which could provide industrial scale quantities of blood, believe it will transform transfusions by preventing hospital shortages, and save thousands of lives on battlefields and at the scene of car crashes. Heart transplant, bypass and cancer patients would also benefit from having a guaranteed supply of blood on hand for their surgery. Breakthrough: The blood made from stem cells would transform blood transfusions by preventing shortages in hospitals and prove a lifesaver on battlefields and at the scene of car crashes The holy grail of blood research, the man-made blood would be free of infections that have blighted natural supplies and could be given to almost everyone regardless of blood group. The hope comes from Edinburgh and Bristol university researchers who have, for the first time, made thousands of millions of red blood c...
Comments